Ir al contenido
Company overview
Team
What we offer
Facilities
Publication track
News
Contact
Menú
Company overview
Team
What we offer
Facilities
Publication track
News
Contact
Publication track
PNAS
A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.
2011 Jul 26
Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma.
2010 Oct 7
Preview
Página
1
Página
2
Página
3
Next
Modeling Science for Cancer Therapy
Contact us